Stay updated on Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s footer “Revision” label was updated from v3.5.2 to v3.5.3, indicating a site or system version change rather than an update to the study record itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:55:10.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:32:38.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Carcinoma of esophagus was added to the conditions list. A Resources section linking to the Genetic and Rare Diseases Information Center was added.
    Difference
    0.2%
    Check dated 2026-04-02T15:21:23.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T04:33:25.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Site revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T20:11:41.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is displayed, and the earlier notices about government funding, operating status, and related updates have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T02:36:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page.